跳至主要内容
临床试验/NCT02617121
NCT02617121Unknown不适用

Comparison of the Prophylactic Anti-emetic Efficacy of Gabapentin and Ramosetron in Patients Undergoing Laparoscopic Gynecological Surgery

Hallym University Medical Center1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
120
试验地点
1
主要终点
Incidence of postoperative nausea and vomiting

研究概览

简要总结

This study was designed to compare the effects of gabapentin and ramosetron on PONV in patients undergoing laparoscopic gynecologic surgery.

详细描述

Postoperative nausea and vomiting (PONV) in the postanesthesia care unit is a common occurrence after general anesthesia. And laparoscopic gynecological surgery is associated with a high incidence of PONV. Several antiemetic agents such as dopaminergic, histaminic and 5-HT3 antagonist (including ondansetron, ramosetron, granisetron) have been used to prevent PONV. Gabapentin, anti-convulsant, has been shown to decrease PONV, as well as chemotherapy induced nausea and vomiting in recent studies, although the exact mechanism against PONV is not known. The purpose of this study was to compare the efficacy of gabapentin and ramosetron in preventing PONV in patients undergoing laparoscopic gynecological surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with ASA physical status 1 and 2 between 20 and 65 years undergoing laparoscopic gynecological surgery with patient-controlled analgesia for postoperative pain control.

排除标准

  • Pregnant women
  • Patients who took sedatives, antiemetics, hypnotics, analgesics, steroid, or gabapentin
  • Patients with neurological deficits
  • Patients with history of drug abuse and allergy of study drugs

研究组 & 干预措施

Gabapentin

Active Comparator

oral gabapentin 300 mg 1 hours before induction of anesthesia

干预措施: Gabapentin (Drug)

ramosetron

Active Comparator

ramosetron 0.3 mg iv at end of surgery

干预措施: Ramosetron (Drug)

Gabapentin and ramosetron

Active Comparator

oral gabapentin 300 mg 1 hours before induction of anesthesia ramosetron 0.3 mg iv at end of surgery

干预措施: Gabapentin and Ramosetron (Drug)

结局指标

主要结局

Incidence of postoperative nausea and vomiting

时间窗: 48 hours postoperative

The incidence of postoperative nausea and vomiting will be assessed during 48 hours after surgery

次要结局

  • sedation score(48 hours postoperative)
  • patient's overall satisfaction score(48 hours postoperative)
  • side effects(48 hours postoperative)
  • pain score(48 hours postoperative)
  • Severity of nausea(48 hours postoperative)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验